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Abstract
A zone of trophoblast specification is established when the embryo is a morula, presumably
reflecting a unique combination of transcription factors in that zone of cells and the influence of
various environmental cues and growth factors on them. A key first step in this process of
specification is the down-regulation of Oct4, a transcription factor that acts as a negative regulator
of trophoblast specification and of genes normally up-regulated as the trophectoderm first forms.
The transcription factors believed to have a positive association with trophectoderm specification
have been inferred primarily in two ways: by their expression patterns in embryos, ES cells and TS
cells and by the consequences of gene disruption on embryonic development. Many of these
transcription factors also control the expression of genes characteristically expressed in
trophoblast but not in the epiblast, primitive endoderm and their derivatives. ES and TS cells from
the mouse and other species are beginning to provide insights into the changes in gene expression
that accompany lineage specification and the subsequent post-specification events that lead to
functional trophoblast derivatives.
Introduction
Trophectoderm is the progenitor tissue of the entire outer
epithelial component of the placenta, known as trophob-
last, and provides the functional bridge between the fetus
and the mother. Trophoblast, which ultimately consists of
a range of terminally differentiated cell types, performs
the majority of the absorptive, immunoprotective and
endocrinological functions of the placenta. Trophecto-
derm differentiates as a simple epithelium, enclosing the
fluid-filled blastocoel cavity and the pluripotent inner cell
mass (i.c.m.). In the mouse, the best studied of all species,
the transition from the morula stage to the blastocyst
occurs at about day 3.5 post fertilization, whereas in
humans and farm species, the process begins a few days
later. Shortly after the formation of the blastocoel, an
additional cell layer, known as either primitive or extrae-
mbryonic endoderm, the precursor of the visceral and
parietal yolk sac, grows out from the blastocoelic surface
of the i.c.m. and along the inner surface of the trophecto-
derm. Although not discussed further in this review, there
is recent evidence from the mouse that the precursors of
primitive endoderm can be identified on blastocysts
between day 3.5 and 4.5 embryos as a group of cells seg-
regating from the rest of the i.c.m. that express the tran-
scription factor GATA6 [1]. Some days after this simple
placenta of two cell layers forms, derivatives of the i.c.m.
provide extraembryonic mesoderm and the precursors of
the allantoic and amniotic membranes.
At about the time that the primitive endoderm emerges as
an identifiable lineage of cells, human and mouse blasto-
cysts are beginning to expand to "hatch" from the
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A comparison of trophoblast lineage derivation in the mouse (upper) and human (lower) Figure 1
A comparison of trophoblast lineage derivation in the mouse (upper) and human (lower). This diagram is based on that of 
Cross et al. [4]. Trophoblast lineage cell types are illustrated in black letters, with the direction of differentiation shown in 
black arrows; other lineages are shown in gray. Key transcription factors that either support or drive differentiation are shown 
adjacent to the arrows. Most of these are discussed in the text. Attempts have been made to illustrate possible homology 
between the two species. Oct4 is expressed in the ICM both species. Mouse trophectoderm is only specified when Oct4 
becomes down-regulated. As discussed in the text, Cdx2 and Eomes are required early in the mouse trophectoderm develop-
ment. Mouse TS cells can be derived from blastocysts and early postimplantation trophoblasts and grow in the presence of 
FGF4. Removal of FGF4 from the TS cell culture causes them to differentiate into trophoblast giant cells and other trophoblast 
subtypes. Human ES cells are derived from blastocyst and maintained in the presence of bFGF. They are able to give rise to all 
cell types of the embryo but can also differentiate into trophoblast cells either spontaneously or in a directed manner when 
provided with BMP4. Id2 is expressed in both mouse chorionic trophoblast and human villous cytotrophoblast [11, 79], while 
Mash2 is expressed in murine spongiotrophoblast and in the cytotrophoblast columns of the human placenta [77, 80]. Hand1, 
is necessary for the formation of mouse giant cells but not for the specification of spongiotrophoblast and syncytiotropphob-
last. By contrast, Mash2 (or Hash2 in the human), has the opposite effect to Hand1. In the giant cell lineage, Hand1 must be 
down-regulated for giant cells to form. The gene mSNA, which represses the transcription of genes that promote the transition 
from mitotic to endoreplicative cell cycles in mouse trophoblast [74], becomes down regulated during giant cell differentiation, 
but has not been studied in other species. Human extravillous cytotrophoblast may be the functional homolog of the rodent 
trophoblast giant cells, although expression of Hand1 has not been detected in human placental villi [75]. On the other hand, 
expression of Gcm1 in mouse labyrinth [76] and human chorionic villi [77, 78] is consistent with structural homology of the 
tissues.
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enclosing zona pellucida. They then quickly attach and
start to implant. In contrast, implantation in many other
species is delayed. In pigs for example, the conceptuses
first expand and then elongate end to end along the vil-
lous folds of the uterus. Even more surprising, the tro-
phoblast never erodes the uterine epithelium of the
mother and never gains direct access to the maternal
blood stream [2]. The situation is only slightly different in
cattle, sheep and other ruminant species, where the inva-
sive component is restricted to a subpopulation of so-
called binucleate cells that fuse with maternal uterine epi-
thelial cells but do not breach the underlying basement
membrane [3]. Not surprisingly, the "end" cells of tro-
phoblast differentiation (Fig. 1) are functionally various
and their relative homologies across species not entirely
clear. For example, there is no obvious equivalent of the
murine spongiotrophoblast in cattle, pigs and their rela-
tives. This structure in the mouse may be equivalent to the
supportive cytotrophoblast cell columns seen in the
invading human trophoblast, but has no obvious
homolog in species where the trophoblast does not
invade [see [4]]. It is possible that the rodent trophoblast
giant cell is the functional homolog of the invasive
extravillous cytotrophoblast cells of humans and the inva-
sive binucleate cells of ruminants and horses, but, since
homologies are not altogether clear, this review concen-
trates on the specification of the early trophoblast. We
focus largely on the transcription factors that play a part in
these early events. Much of the genetic and developmental
information has been derived from the mouse where
most information exists (Fig. 1), but wherever possible we
have ventured into comparative placentation, particularly
where some obvious threads of connection exist across
species.
Specification of trophectoderm in the mouse
At the time the mouse blastocyst implants, it contains
three types of cell: epiblast (or i.c.m.), primitive endo-
derm, and trophectoderm. The segregation of the lineages
appears to occur according to the positions that the cells
occupy in the compacted morula, so that by the time the
blastocyst is ready to implant, the three lineages are no
longer interconvertible [1], although they continue to
exhibit interdependence during subsequent post-implan-
tation development. In modern parlance, each lineage has
its own population of stem cells and expresses its own
characteristic set of genes by the time the embryo consists
of 32 to 64 cells. This patterning is achieved by the action
of transcription factors, whose combinatorial expression,
most probably directed by growth factors and fine-tuned
by environmental inputs such as oxygen and nutrient
availability, establishes boundaries of cell lineage specifi-
cation within the early embryo.
Transcription factors involved in trophoblast lineage 
specification
Knockout experiments in the mouse have revealed many
genes that when deleted cause embryonic lethality. Some-
times these defects arise from failure within the epiblast
lineage, but a significant number of such mutations cause
the trophoblast to develop improperly and the conceptus
to die before a fully functional placenta is formed [1,4-8].
The majority of such mutations affecting the trophoblast
have been discovered by chance when the investigators
were in reality hoping to observe a phenotype in the adult
animal, but were instead confronted by a failure to obtain
homozygous mutants that died well before birth.
Other knockouts have been intentionally engineered after
noting an association in expression of a particular gene
with a specific placental cell type or after cloning out
expressed cDNA from placental tissues. Examples of the
latter have included knockouts for several genes encoding
transcription factors that have been associated with some
of the developmental transitions shown in Fig. 1. Thus,
the basic helix-loop-helix (bHLH) gene, Hand1, is neces-
sary for the formation of mouse giant cells but not for the
specification of spongiotrophoblast and syncytiotrophob-
last. By contrast, Mash2 (or Hash2 in the human) another
bHLH gene, seems to have an opposing effect to Hand1 in
the giant cell lineage and must be down-regulated for
giant cells to form. Likewise, the gene, Gcm1, must be
active for syncytiotrophoblast to develop from its precur-
sors. This ability to limit a particular developmental tran-
sition in the trophoblast does not imply that these factors
are expressed exclusively in that lineage of cells. For exam-
ple, the Hand1 gene is expressed in heart and several other
tissues derived from the epiblast [9]. Presumably, it is not
the presence of either single transactivators or silencing
factors that drive specification events, but a combination
of such factors in the correct proportions within the con-
text of the precursor cell (Fig. 1). For example, several
additional positive and negative regulators have been
implicated in the formation of trophoblast giant cells
from their mitotic precursors. These include mSNA (a zinc
finger transcription factor) [74], SOCS3 (a suppressor of
cytokine signaling) [10], Id2, which is a dominant-nega-
tive antagonist of bHLH transcription factors [11], and the
orphan nuclear receptor Errβ [12]. As the products identi-
fied in genetic screens for trophoblast-expressed genes
increase and are further analyzed, the list of transcription
factors involved in lineage specification will undoubtedly
grow too [13].
Some transcription factors that are widely expressed in
adult and fetal tissues have been demonstrated in knock
out studies to be required for placental development.
Good examples are Ets2 [14], AP-2γ [15,16], and some of
the subunit genes for AP-1 [17,18]. In each case,Reproductive Biology and Endocrinology 2004, 2:47 http://www.rbej.com/content/2/1/47
Page 4 of 9
(page number not for citation purposes)
blastocysts form and implant, but the trophoblast exhibits
early abnormalities, and the conceptus soon dies. The role
of these familiar transcription factors in lineage-specific
events is of particular interest as they also regulate produc-
tion of characteristic secretory products of trophoblast
(discussed later).
Genes required for initial trophectoderm specification
Some murine genes, when deleted, cause developmental
failure before or at implantation. A good example is the
POU-domain transcription factor, Oct4 (encoded by
Pou5f1, we refer here as Oct4). Normally, Oct4 is expressed
in the nuclei of all cells of the cleavage stage embryo, but
by the time the blastocyst forms, its expression is restricted
to the i.c.m. [19]. When the gene is knocked out, however,
no i.c.m. forms and all cells of the embryo default to tro-
phectoderm [20]. Accordingly, trophectoderm is only
specified in the mouse when Oct4 becomes down-regu-
lated. This generality does not apply across all species,
however. In bovine embryos, Oct4 can be detected in tro-
phectoderm until day 10, two to three days after the blas-
tocyst first forms [21,22], although its expression there is
clearly lower than in the i.c.m. (Fig. 2). Indeed it may be
that the mouse is the exception rather than the rule, since
Oct4 is also expressed in early human trophectoderm
[23]. These observations indicate that Oct4 is not a binary
off-on switch but that its dosage is critical.
The Sox2 transcription factor exhibits a similar expression
pattern to Oct4 during early development of the mouse
except that it remains active in trophectoderm. Its deletion
causes early post implantation failure, but does not pre-
vent blastocyst formation and the differentiation of troph-
ectoderm. Sox2 is, however, important in lineage
specification because it and Oct4 together regulate the
production of FGF4 by the epiblast, a necessary growth
Oct-4 expression in an in vitro-derived d10 bovine embryo Figure 2
Oct-4 expression in an in vitro-derived d10 bovine embryo. Strong Oct-4 nuclear immunofluorescence (left panel; red) is 
detected in the i.c.m. at the left pole of the embryo, while weaker, more diffuse immunofluorescence is present over trophec-
toderm. DAPI nuclear staining (blue) is shown in the center panel. In the right panel, Oct-4 (red) and DAPI (blue) signals have 
been merged. The merged image indicates that, whereas all nuclei of the i.c.m. are strongly Oct-4 positive, Oct-4 signals are 
weaker and more variable over trophectoderm, with some cells apparently Oct-4 negative. Controls performed with a non-
relevant IgG failed to show nuclear staining (not shown). Positive controls (also not shown) with the anti-Oct-4 IgG provided 
nuclear staining in undifferentiated F9 embryonic carcinoma cells but not in JAr choriocarcinoma cells (data not shown). The 
bovine embryos were fixed with 2% paraformaldehyde-PBS for 30 min at room temperature, permeabilized with 1% Triton X-
100 for 30 min, and incubated overnight at 4 C with primary antibody (affinity purified rabbit anti-Oct-4 IgG in PBS; T.E., R.M.R. 
unpublished) at a concentration of 4 ng/µl. After washing, the blastocysts were exposed to secondary antibody (goat anti-rabbit 
IgG conjugated with Alexa Fluor 568; Molecular Probes, Eugene, OR) diluted 1:1000. Nuclear staining was performed with 
DAPI (Sigma, St. Louis, MO) at a concentration of 5 ng/µl. Bars represent 100 µm. Images were captured by using a Nikon 
Eclipse 800 microscope equipped with a CoolSnap HQ RTE/CCD 1217 digital camera operated by MetaMorph 4.6 software 
(Universal Imaging Corp., Downington, PA) and edited by Adobe Photoshop 6.0.
Oct4 Nuclear stain (DAPI) Merged signals Oct4 Nuclear stain (DAPI) Merged signalsReproductive Biology and Endocrinology 2004, 2:47 http://www.rbej.com/content/2/1/47
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factor for trophectoderm proliferation [[1,8,24], and
references therein]. Accordingly, Oct4 has a dual role. Its
down-regulation is permissive for trophectoderm to be
specified, but its expression with Sox2 in the i.c.m. leads
to the production of a required trophoblast growth factor.
As pointed out by Rossant et al. [1], the formation of tro-
phectoderm is not simply a default pathway initiated by
the down-regulation of Oct4, but probably requires spe-
cific transcription factors. One of these is the homeodo-
main protein, Cdx2, and another is the T-box gene Eomes.
Both show a reciprocal pattern of expression to Oct4 at the
blastocyst stage [25,26], i.e. they are absent from the i.c.m.
but expressed in trophectoderm. Cdx2 [27] and Eomes [28]
knockout embryos fail to implant, although they develop
to the early blastocyst stage but generally advance no fur-
ther, and do not form trophoblast outgrowths when cul-
tured. Finally, Cdx2-/- embryos cannot be coaxed to
produce trophectoderm stem cells [8]. It seems fair to con-
clude that Cdx2 and Eomes are required early in the devel-
opment of trophectoderm, but possibly not in its earliest
specification. At a minimum, murine trophectoderm
requires the down-regulation of Oct4 followed by the up-
regulation of Cdx2, Eomes. For the lineage to expand, the
i.c.m. must produce the Sox2/Oct4-regulated FGF4
growth factor (Fig. 1). Whether these general rules apply
universally across species remains unclear.
ES cells, trophoblast stem (TS) cells, and their 
interrelationship
Embryonic stem (ES) cells can now be routinely derived
from the isolated i.c.m. of mouse blastocysts and main-
tained in a continuously dividing, undifferentiated mode
as long as the cytokine leukemia inhibitory factor (LIF) is
provided in the medium [[1,8] and references therein].
These cell lines are generally pluripotent and able to give
rise to a variety of differentiated cell types when LIF is
withdrawn.
ES cell lines have been derived from two species of mon-
key [29] and from human blastocysts [30]. Paradoxically,
the primate cell lines fail to show any dependence on LIF
for continued proliferation in the undifferentiated state.
Instead of LIF, these cells need basic FGF (bFGF; Fig. 1)
and the support of additional factors that are best sup-
plied by a "feeder" layer of embryonic fibroblasts [31]. ES
cells from these primate species can be induced during in
vitro culture to progress to a wide range of differentiated
cell types and are considered, like those from mouse, to be
pluripotent. This pluripotency endows ES cells with excit-
ing potential for use in tissue repair and replacement. In
the case of the mouse, pluripotency has been demon-
strated conclusively by introducing the cells into blasto-
cysts, where they colonize the i.c.m. rather than
trophectoderm and ultimately contribute to the entire
embryo, including the germ cells [see [1,8]]. The failure of
mouse ES cells to form trophoblast in such chimeras and
not to differentiate into trophoblast cells in culture is puz-
zling since the ES cells derived from primate embryos
spontaneously form trophoblast over time and can be
induced to do so rapidly if supplied with the growth factor
BMP4 [32]. Whether BMP4 is the signal for trophoblast
differentiation in vivo remains to be determined. Such a
determination will require either a genetic knock out
approach, which can only ethically be performed on pri-
mates, or the use of RNAi or other silencing technologies
whose outcome is often equivocal.
There are, however, circumstances when mouse ES cells
can be directed towards trophoblast. The effects of mutat-
ing both copies of the Oct4 gene on embryo development
has been noted earlier [20], and conditional knock out of
the same gene in cultured ES cells causes cells expressing
trophoblast markers to appear in culture [33]. On the
other hand, removal of LIF, which effectively causes Oct4
to be silenced, does not lead to directed or widespread tro-
phoblast differentiation of ES cell colonies. Instead, other
differentiated cell types appear [34]. To explain this para-
dox, Hemburger et al. [35] have suggested that mouse ES
cells contain some trophectoderm precursor cells at a low
frequency. They have gone on to show that disruption of
the gene for the enzyme poly(ADP-ribose) polymerase
(Parp1) increases the likelihood of mouse ES cells
differentiating spontaneously towards trophoblast. It
seems conceivable that the difference between the primate
ES cell, which tends to form trophoblast readily, and the
mouse ES cell, which does not, may not be as profound as
previously thought. Slight differences in responses to
external signals, possibly the result of differences in recep-
tor numbers or intracellular signaling pathways, and in
the expression levels of a few key genes may be sufficient
to favor one pathway of "spontaneous" differentiation
over another. It should be recalled that mouse and human
stem cells require different growth conditions to continue
dividing and to remain pluripotent. Mouse ES cells need
LIF, whereas LIF seems unimportant to human ES cells,
which have a requirement for bFGF instead.
Cells with some features of ES cells have been derived
from domestic species, such as sheep, cattle and swine
[36-40], but there has been little follow-up since. It
remains unclear whether or not these cells can transform
into trophoblast, although they can form an array of dif-
ferentiated derivatives suggestive of an epiblast origin.
Trophoblast stem (TS) cells, seemingly capable of forming
only trophectoderm derivatives, i.e. restricted in their
developmental potential, have been isolated for mouse
but not yet from primate embryos (unless primate ES cells
are regarded also as TS cells). Two approaches have beenReproductive Biology and Endocrinology 2004, 2:47 http://www.rbej.com/content/2/1/47
Page 6 of 9
(page number not for citation purposes)
used to derive murine TS cells. The first has been to culture
trypsin-dissociated cells from the ectoplacental cone of
implanting day 6.5 mouse embryos [41]. The second has
been to use primary outgrowths from cultured blastocysts
[8]. In both, FGF4 and a growth medium conditioned by
embryonic fibroblasts were critical requirements for the
cells to proliferate. Removal of FGF4 led to spontaneous
differentiation into trophoblast giant cells and the expres-
sion of a range of genes characteristic of end-stage tro-
phoblast. A requirement for FGF4 was inferred from
expression patterns in early embryos where it is expressed
only by the epiblast and its precursor, the i.c.m. [1,8,42].
In contrast, its receptor first appears in outer blastomeres
of morulae and then becomes localized on trophecto-
derm [43,44]. Moreover, embryos lacking either a func-
tional gene for FGF4 [45] or for FGFR2 [46], its receptor,
fail to grow after implantation.
Various bovine, ovine, porcine and caprine trophoblast
cell lines have been described [47-52], although, as dis-
cussed below, their status as continuously proliferating
stem cells is unclear. One reasonably well characterized
bovine cell line, CT-1, which was derived from a blasto-
cyst outgrowth, has special growth requirements, best pro-
vided by a feeder layer of fibroblasts, and expresses genes,
such as those for interferon (IFN)-τ [53], pregnancy-asso-
ciated glycoproteins and trophoblast Kunitz-domain pro-
teins characteristic of the bovine trophoblast lineage (J.
MacLean, J. Green, & R.M. Roberts, unpublished results).
Whether CT-1 or any of the other trophoblast lines are
truly stem cells, representing the very earliest stages of lin-
eage specification, is unclear, since they clearly express
post-specification genes. They may be progenitor cells,
one step along the committed lineage. They have not been
well studied with regard to either gene expression or their
capacity to differentiate in response to external cues.
There are, in addition, to the cell lines described above a
number of trophoblast lines derived from tumors. These
include the rat Rcho cell line [54], and an analogous
human embryonal carcinoma line HT-H [55]. In both
lines, dividing cells easily detach from substratum, but
differentiate spontaneously under crowded culture condi-
tions to larger, adherent cells with a more differentiated
phenotype. Rcho cultures convert to giant cells with
endoduplicated DNA in their nuclei and produce placen-
tal lactogen (PL)-I and -II, while HT-H cells form what
resembles syncitial trophoblast that are active in steroid
synthesis and hCG production. Such cell lines are proving
to be valuable in following changes in gene expression
that accompany differentiation. There are, in addition,
many cell lines that have been derived from human chor-
iocarcinomas, the best known of which are JAr, BeWo,
and Jeg-3. Exactly where these cells fit in the in the human
trophoblast lineage is unclear, but like Rcho and HT-H
cells, they are probably transformed derivatives of early
stage trophoblast progenitor cells. Human choriocarci-
noma cell lines have been invaluable in determining the
processes that control expression of trophoblast products
such as hCG, placental lactogens, and steroid hormones
[56].
Transcriptional profiling of differentiating TS cells
Attempts are being made to use various types of transcrip-
tional profiling to define the phenotype of differentiating
of TS cells, and the changes that occur over time as such
cells differentiate [41,57-59]. Oct4, for example, is not
detectable in murine TS cells, while the transcription fac-
tors Errβ, Cdx2, and mEomes are strongly expressed when
the cells are proliferating, but down-regulated as differen-
tiation begins and when markers such as PL-I begin to
appear.
Microarrays have been employed to follow the BMP4-
induced transition of human ES cells to cells that actively
produce hCG, HLA-G, estradiol and progesterone [32].
After 7 days of BMP4 treatment, the mRNA for two genes
characteristic of pluripotent ES cells, Oct4 and telomerase
reverse transcriptase (TERT), had significantly decreased.
In contrast, BMP4 rapidly up-regulated some transcrip-
tion factors, including Cdx2, GATA2, GATA3, and AP-2
genes (TFAP2), which had been previously implicated in
either placental development or in regulating genes
characteristically expressed in differentiating trophoblast.
Curiously, the human orthologs of two other transcrip-
tion factors, Errβ and Mash2, which have been discussed
earlier in relation to their likely central role in specifying
mouse trophoblast (Fig. 1), were expressed in the original
ES cells and showed no significant change in response to
BMP4. Attempts to make sense of this microarray infor-
mation and to make valid comparisons across species are
confounded by the sheer volume of the data and by the
fact that the cultures undoubtedly contain a range of cell
types. Resolving the inconsistencies will not be easy.
Transcription factors that control expression of 
trophoblast products
As trophectoderm emerges and then progresses to form
the end-stage cells of mature trophoblast, a series of char-
acteristic products, including several hormones, are
released that play important roles in maintaining the
pregnancy. For example, IFN-τ, the luteoprotective hor-
mone of ruminant species, is first produced by the early
bovine blastocyst and is massively up-regulated a few days
later [60,61]. A somewhat similar situation has been
observed for hCG production in the human [62] and PL-I
production by the mouse [63]. Analysis of the promoters
regions of such genes has revealed that they are under the
control of many of the same transcription factors, that,
when knocked out in the mouse, cause trophoblast devel-Reproductive Biology and Endocrinology 2004, 2:47 http://www.rbej.com/content/2/1/47
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opment to fail. A good example is Ets2, a gene essential for
placenta formation in the mouse [14]. Ets2 is also a key
transcriptional regulator of the IFN-τ genes (IFNT) in cat-
tle and sheep [64], the hCGα  and -β  subunit genes
[65,66], and CYP11 (P-450 side-chain cleavage enzyme)
genes in human [67], and the PL-II gene in the mouse
[68]. Ets2 also regulates the urokinase-type plasminogen
activator and several metalloproteinases, including
MMP9, likely to be involved in invasive implantation
[69,70]. Cross et al. [4] discusses additional examples of
transcription factors that regulate both trophoblast devel-
opment and placental hormone production. It seems rea-
sonable to conclude that many of the same genes that
control cell fate in the trophoblast lineage also control the
transcription of genes characteristically expressed in dif-
ferentiated, end-stage trophoblast cells.
Several, possibly the majority, of the genes that are tran-
scriptionally up-regulated as trophectoderm first forms
and differentiates are silenced by Oct4 [see [71]]. We have
suggested that one way that Oct4 acts in pluripotent ES
cells and in epiblast is to silence the expression of genes
that are lineage-specific for trophectoderm, such as those
encoding the hCGα and -β subunits [72,73], and IFNT
[71]. Once Oct4 itself is down-regulated, this restraint is
relieved and the genes can come under the control of tran-
scriptional activators.
Conclusions
A zone of trophoblast specification is established when
the embryo is a morula, presumably reflecting a unique
combination of transcription factors in that zone of cells
and the influence of various environmental cues and
growth factors on them. A key first step in this process of
specification is the down-regulation of Oct4, a transcrip-
tion factor that acts as a negative regulator of trophoblast
specification and of genes normally up-regulated as the
trophectoderm first forms. The transcription factors
believed to have a positive association with trophecto-
derm specification have been inferred primarily in two
ways: by their expression patterns in embryos, ES cells and
TS cells and by the consequences of gene disruption on
embryonic development. Many of these transcription fac-
tors also control the expression of genes characteristically
expressed in trophoblast but not in the epiblast, primitive
endoderm and their derivatives. ES and TS cells from the
mouse and other species are beginning to provide insights
into the changes in gene expression that accompany line-
age specification and the subsequent post-specification
events that lead to functional trophoblast derivatives.
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